Scholars Central

Conference abstractPublished 15 Aug 2011

Expression of the p53 target SERPINE1 (PAI-1) gene is required for human tumor cell migration upon plastic conversion to a stem cell-like phenotype in response to TGF- β1+EGF

Authors: Paul J. Higgins

Albany Medical College, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The emergence of highly aggressive, cancer stem cell-like, subtypes of human squamous cell carcinoma (SCC) reflects increased transforming growth factor-Ã?²1 (TGF-Ã?²1) synthesis and epidermal growth factor receptor (EGFR) amplification. Cooperative TGF-Ã?²/EGFR signaling promotes cell migration and induces expression/activation of proteases (e.g., plasminogen, MMPs) and protease inhibitors that regulate stromal remodeling resulting in the acquisition of an invasive phenotype. Paradoxically, plasminogen activator inhibitor type-1 (SERPINE1,PAI-1), the major inhibitor of plasmin generation, is also upregulated under these conditions and is an early event in tumor progression. Increased PAI-1 expression temporally and spatially modulates plasmin-initiated pericellular proteolysis, preserving a stromal scaffold permissive that facilitates invasive potential. Combined TGF-Ã?²1+EGF treratment was used to investigate mechanisms underlying induced epithelial-to-mesenchymal transition (EMT) in ras-transformed human keratinocytes. Dual stimulation with TGF-Ã?²1+EGF resulted in keratinocyte âÂ?Â?plasticityâÂ? and pronounced colony dispersal. Transcriptome analyses indicated that cells undergoing EMT expressed high Ã?²1 integrin levels and possessed stem cell-like characteristics. The most up-regulated transcript encoded PAI-1, an established marker of aggressive carcinoma cells and a functional promoter of cell migration suggesting that PAI-1 plays a critical role in epithelial stem cell biology. PAI-1 knockdown alone effectively inhibited TGF-Ã?²1+EGF-dependent cell scattering, indicating a functional role for this SERPIN in the dual-growth factor model of induced motility. Identification of signaling networks and their effect on specific invasion-promoting target genes, such as PAI-1, may lead to the development of pathway-specific therapeutics that impact late-stage events in human cutaneous epithelial tumor progression. Supported by grants from the NIH (GM57242) and the NYSDOH Empire State Stem Cell Trust Fund (C024312).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Paul J. Higgins”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels